DK1230223T3 - Oligobenzimidazolderivater og deres anvendelse som midler til DNA-transfektion - Google Patents

Oligobenzimidazolderivater og deres anvendelse som midler til DNA-transfektion

Info

Publication number
DK1230223T3
DK1230223T3 DK00976109T DK00976109T DK1230223T3 DK 1230223 T3 DK1230223 T3 DK 1230223T3 DK 00976109 T DK00976109 T DK 00976109T DK 00976109 T DK00976109 T DK 00976109T DK 1230223 T3 DK1230223 T3 DK 1230223T3
Authority
DK
Denmark
Prior art keywords
nucleic acids
group
agents
dna transfection
vivo
Prior art date
Application number
DK00976109T
Other languages
English (en)
Inventor
Daniel Scherman
Michel Bessodes
Javier Soto
Gerardo Byk
Bruno Pitard
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9913934A external-priority patent/FR2800736B1/fr
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Application granted granted Critical
Publication of DK1230223T3 publication Critical patent/DK1230223T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/18—Benzimidazoles; Hydrogenated benzimidazoles with aryl radicals directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/20—Two benzimidazolyl-2 radicals linked together directly or via a hydrocarbon or substituted hydrocarbon radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
DK00976109T 1999-11-05 2000-11-06 Oligobenzimidazolderivater og deres anvendelse som midler til DNA-transfektion DK1230223T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9913934A FR2800736B1 (fr) 1999-11-05 1999-11-05 Derives d'oligobenzimidazoles, les compositions les contenant et leurs utilisations
US17464800P 2000-01-05 2000-01-05
PCT/FR2000/003087 WO2001032630A1 (fr) 1999-11-05 2000-11-06 Derives d'oligobenzimidazoles et leur utilisation comme agents de transfection d'adn

Publications (1)

Publication Number Publication Date
DK1230223T3 true DK1230223T3 (da) 2004-06-14

Family

ID=26235148

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00976109T DK1230223T3 (da) 1999-11-05 2000-11-06 Oligobenzimidazolderivater og deres anvendelse som midler til DNA-transfektion

Country Status (12)

Country Link
EP (1) EP1230223B1 (da)
JP (1) JP2003513078A (da)
AT (1) ATE260261T1 (da)
AU (1) AU1399801A (da)
CA (1) CA2389778A1 (da)
DE (1) DE60008573T2 (da)
DK (1) DK1230223T3 (da)
ES (1) ES2211644T3 (da)
IL (1) IL149153A0 (da)
MX (1) MXPA02004449A (da)
PT (1) PT1230223E (da)
WO (1) WO2001032630A1 (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0320627D0 (en) * 2003-09-03 2003-10-01 Imp College Innovations Ltd Methods
GB201506660D0 (en) 2015-04-20 2015-06-03 Cellcentric Ltd Pharmaceutical compounds
GB201506658D0 (en) 2015-04-20 2015-06-03 Cellcentric Ltd Pharmaceutical compounds

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ207393A (en) * 1983-08-05 1987-03-31 Neal Lloyd First Staining dna in living cells
NZ239893A (en) * 1990-09-25 1993-11-25 Hoechst Japan A method for introducing a foreign dna into a cell

Also Published As

Publication number Publication date
ES2211644T3 (es) 2004-07-16
DE60008573T2 (de) 2004-12-16
WO2001032630A1 (fr) 2001-05-10
CA2389778A1 (fr) 2001-05-10
AU1399801A (en) 2001-05-14
MXPA02004449A (es) 2002-09-02
EP1230223A1 (fr) 2002-08-14
DE60008573D1 (de) 2004-04-01
IL149153A0 (en) 2002-11-10
EP1230223B1 (fr) 2004-02-25
PT1230223E (pt) 2004-07-30
JP2003513078A (ja) 2003-04-08
ATE260261T1 (de) 2004-03-15

Similar Documents

Publication Publication Date Title
TW200833329A (en) 2-aryl-6-phenylimidazo[1,2-a]pyridine derivatives, preparation thereof and therapeutic use thereof
BR0008770A (pt) Derivado de pirimidina, processo para a preparação de um derivado de pirimidina, processo para a produção de um efeito anti-câncer em um animal de sangue quente, uso de um derivado de pirimidina, e, composição farmacêutica
BR0309710A (pt) Composição ácida espessada e usos da mesma
DK0659174T3 (da) Derivater af valproinsyre og 2-valproensyreamider samt deres anvendelse som antikonvulsive midler
TW200607808A (en) Pyrido-pyrimidine derivatives, preparation thereof and application thereof
TW200612920A (en) Novel imidazolidine derivatives
CA2247167A1 (en) 2-hetaroylcyclohexane-1,3-diones
DE69818042D1 (de) Flüssige benzisochinoline derivate
HUP0203117A2 (hu) Semleges kationos lipid nukleinsav és hatóanyag szállítására
MXPA03000547A (es) Uso de derivados de amidas de acido valproico y de acido 2-valproenico, para el tratamiento de manias en trastornos bipolares.
MY146939A (en) Derivatives of 7-alkynyl-1,8-naphthyridones, preparation method thereof and use of same in therapeutics
AR036176A1 (es) Un derivado de fenil-acetamido-tiazol, un procedimiento para su preparacion, una composicion farmaceutica que lo comprende, un producto o kit que los comprende, y un metodo que utiliza dicho derivado
EP1342720A3 (en) Epoxysuccinamide derivatives
DK1230223T3 (da) Oligobenzimidazolderivater og deres anvendelse som midler til DNA-transfektion
BRPI9707889B8 (pt) composto e seus sais, composição farmacêutica, utilização do composto.
MX2009005782A (es) Derivados de pirano, procedimiento de preparacion y uso de los mismos en perfumeria y saborizantes.
HRP20000733B1 (en) NOVEL OCTAHYDRO-6,10-DIOXO-6H-PYRIDAZINO/1,2-a/ /1,2/DIAZEPIN-1-CARBOXYLIC ACID DERIVATIVES, PREPARATION METHOD AND USE FOR PREPARING THERAPEUTICALLY ACTIVE COMPOUNDS
CR6503A (es) Derivados de- 1-trifluorometil-4-hidroxi-7-piperidinil-aminometiclcromano
NO20035026D0 (no) Dihydroimidazo [5,1-A]-<beta>-karbolinderivater, fremgangsmåte til deres fremstilling og anvendelse derav som legemiddel
DE60004669D1 (de) Indolocarbazolalkaloide aus einer marinen actinomycete
CO6331311A2 (es) Derivados de n-heterociclico-6-heterociclico-imidazo[1,2-alfa]piriidina-2-carboxamidas su preparacion y su aplicacion en terapeutica
ES2111330T3 (es) Derivados de 5-(1-fluor-vinil)-1h-pirimidina-2,4-diona que son utiles como agentes neoplasicos.
IL106564A (en) Tetrahydronaphthalene derivatives their preparation and pharmaceutical compositions containing them
TW200942538A (en) 2-benzoylimidazo[1,2-a]pyridine derivatives, preparation thereof and therapeutic use thereof
AU2002321381A1 (en) Method for preparing organic, in particular lithocholic acid, nanotubes and uses thereof